EDA-Based Adaptive Support in VR ALS Training

June 11, 2026 updated by: Acibadem University

Effects of Electrodermal Activity-Based Adaptive Support Systems on Performance in VR-Based Advanced Life Support Training: A Randomized Controlled Study

This randomized controlled study aims to investigate the effects of an electrodermal activity (EDA)-based adaptive support system on performance during virtual reality (VR)-based advanced life support (ALS) training. Participants' stress levels will be continuously monitored through EDA during the simulation. When stress exceeds a predefined threshold, the adaptive system will automatically activate a support mode that provides additional guidance and time. The performance outcomes of participants receiving adaptive support will be compared with those receiving standard VR training. The study will also examine the role of presence, anxiety, social anxiety, and personality traits in the relationship between stress and performance.

Study Overview

Detailed Description

This study is a randomized controlled trial designed to evaluate whether an electrodermal activity (EDA)-based adaptive support system can improve performance in VR-based advanced life support (ALS) training. The research focuses on integrating physiological stress monitoring into automated VR simulation systems to create a more responsive and individualized learning environment.

Simulation-based education is widely used in medical training because it enables learners to practice high-risk clinical procedures in a safe and controlled environment. However, most automated VR training systems currently provide standardized instruction regardless of participants' stress levels or individual needs. Since acute stress may negatively influence cognitive and psychomotor performance during complex medical tasks, adaptive systems that dynamically respond to learners' stress may improve educational outcomes.

The study will recruit 72 volunteer second-year anesthesia technician students from Acıbadem Mehmet Ali Aydınlar University. Participants will be randomly assigned to either an adaptive-support condition or a standard-training control condition. Before the experimental phase, all participants will complete a standardized ALS preparatory training and competency assessment to ensure comparable baseline knowledge levels across groups.

During VR-based ALS training, participants' EDA levels will be continuously recorded using a non-invasive physiological monitoring system. Baseline EDA measurements will first be collected during a resting period. In the adaptive-support condition, when a participant's EDA exceeds a predefined threshold indicating elevated stress, the system will automatically activate a support mode. This mode will provide additional guidance, more frequent instructions, and extended response time during the simulation. Participants in the control group will continue the simulation under standard conditions without adaptive modifications.

After completing the training, all participants will undergo the same VR-based performance examination without guidance. Performance will be automatically evaluated by the simulation system. In addition to performance outcomes, participants will complete self-report measures assessing presence, state and trait anxiety, social anxiety, and personality traits. These measures will allow the researchers to investigate how individual differences influence stress responses, presence experiences, and training outcomes in adaptive VR environments.

The findings of this study are expected to contribute to the development of more flexible, personalized, and physiologically responsive VR-based medical training systems. The project may also provide empirical evidence for integrating real-time psychophysiological monitoring into automated simulation-based education.

Study Type

Interventional

Enrollment (Estimated)

72

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being older than 18

Exclusion Criteria:

  • prior completion of ALS training
  • history of virtual reality (VR)-induced motion sickness
  • medical conditions such as vertigo or the use of medications known to cause vertigo-like symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adaptive Support
Participants in this arm will receive VR-based advanced life support training with an electrodermal activity (EDA)-based adaptive support system. During the simulation, participants' stress levels will be continuously monitored using EDA measurements. When stress exceeds a predefined threshold, the system will automatically activate a support mode that provides additional guidance, more frequent instructions, and extended response time.
Participants receive VR-based advanced life support training with an electrodermal activity (EDA)-based adaptive support system that automatically provides additional guidance, more frequent instructions, and extended response time when stress levels exceed a predefined threshold.
Experimental: Standard Training
Participants in this arm will receive standard VR-based advanced life support training without adaptive support. Although electrodermal activity (EDA) will be recorded throughout the simulation, the training flow will remain unchanged regardless of participants' stress levels, and no additional guidance or time adjustments will be provided.
Participants receive standard VR-based advanced life support training without adaptive support. Although electrodermal activity (EDA) is monitored during the simulation, the training flow remains unchanged regardless of stress levels.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Advanced Life Support Performance Score
Time Frame: Up to 4 weeks
Participants' performance during the post-training VR-based advanced life support examination will be automatically evaluated by the simulation system. The score will reflect the accuracy and completeness of advanced life support procedures performed without guidance.
Up to 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electrodermal Activity (EDA) Level
Time Frame: Up to 4 weeks

Description:

Participants' physiological stress responses during the VR simulation will be continuously measured using electrodermal activity recordings. Baseline and training-phase EDA values will be analyzed.

Up to 4 weeks
Presence Score
Time Frame: Up to 4 weeks
Participants' sense of presence in the VR environment will be assessed using the Turkish adaptation of the Presence Questionnaire developed by Witmer and Singer (1998). Higher scores indicate a stronger sense of immersion and realism in the virtual environment.
Up to 4 weeks
State Anxiety Score
Time Frame: Up to 4 weeks
articipants' situational anxiety levels following the VR training will be assessed using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI).
Up to 4 weeks
Trait Anxiety Score
Time Frame: Up to 4 weeks
Participants' general tendency toward anxiety will be assessed using the Trait Anxiety subscale of the State-Trait Anxiety Inventory (STAI).
Up to 4 weeks
Social Anxiety Score
Time Frame: Up to 4 weeks
Participants' social anxiety levels will be assessed using the Liebowitz Social Anxiety Scale, which evaluates anxiety and avoidance in social and performance situations.
Up to 4 weeks
Personality Traits
Time Frame: Up to 4 weeks
Participants' personality characteristics will be assessed using the Ten-Item Personality Inventory, which measures extraversion, agreeableness, conscientiousness, emotional stability, and openness to experience.
Up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

June 11, 2026

First Submitted That Met QC Criteria

June 11, 2026

First Posted (Actual)

June 16, 2026

Study Record Updates

Last Update Posted (Actual)

June 16, 2026

Last Update Submitted That Met QC Criteria

June 11, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adaptive Support Condition

Clinical Trials on EDA-Based Adaptive Support System

Subscribe